Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Assembly Biosciences (ASMB) over the last 10 years, with Q3 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Interest & Investment Income rose 2561.43% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2054.66%. This contributed to the annual value of $5.6 million for FY2024, which is 6148.94% up from last year.
  • Latest data reveals that Assembly Biosciences reported Interest & Investment Income of $1.7 million as of Q3 2025, which was up 2561.43% from $895000.0 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Interest & Investment Income ranged from a high of $1.7 million in Q3 2025 and a low of $58000.0 during Q1 2021
  • Moreover, its 4-year median value for Interest & Investment Income was $895000.0 (2025), whereas its average is $868733.3.
  • In the last 5 years, Assembly Biosciences' Interest & Investment Income plummeted by 9441.77% in 2021 and then soared by 17126.44% in 2024.
  • Assembly Biosciences' Interest & Investment Income (Quarter) stood at $101000.0 in 2021, then skyrocketed by 1505.94% to $1.6 million in 2023, then tumbled by 30.89% to $1.1 million in 2024, then soared by 50.49% to $1.7 million in 2025.
  • Its Interest & Investment Income was $1.7 million in Q3 2025, compared to $895000.0 in Q2 2025 and $1.1 million in Q1 2025.